Cosmo Pharmaceuticals
C43.F
$77.61
Share price
-2.68%
Change (1 day)
30.92%
Change (1 year)
Categories
Operating Margin for Cosmo Pharmaceuticals (C43.F)
Operating Margin at the end of 2021: 36.89%
According to Cosmo Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 36.88%. At the end of 2021 the company had an Operating Margin of 36.89%.
Operating Margin history for Cosmo Pharmaceuticals from 2004 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 36.89% | -424.36% |
| 2020 | -11.37% | -66.64% |
| 2019 | -34.09% | 28.12% |
| 2018 | -26.61% | -44.83% |
| 2017 | -48.23% | -218.71% |
| 2016 | 40.63% | -90.32% |
| 2015 | 419.57% | 206.8% |
| 2014 | 136.76% | 7.56% |
| 2013 | 127.15% | 181.54% |
| 2012 | 45.16% | 66.43% |
| 2011 | 27.14% | 95.05% |
| 2010 | 13.91% | -30.18% |
| 2009 | 19.93% | -41.37% |
| 2008 | 33.98% | 4764.23% |
| 2007 | 0.70% | -86.81% |
| 2006 | 5.30% | -37.34% |
| 2005 | 8.45% | -176.44% |
| 2004 | -11.06% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.